ERA is in the process of being migrated to Scholaris, a Canadian shared institutional repository service (https://scholaris.ca). Deposits and changes to existing ERA items and collections are frozen until migration is complete. Please contact erahelp@ualberta.ca for further assistance
Search
Skip to Search Results- 2Sigalet, David L.
- 2Yamoah, Ebenezer Nketia.
- 1Aboelnazar, Nader Saber
- 1Abualhassan, Nasser
- 1Adegoke, Adeolu
- 1Aggarwal, Saloni
- 7Mesenchymal stem cells
- 7Scars
- 6Diabetes
- 6Islet transplantation
- 5Cerebrovascular spasm--Animal models
- 5Fibroblasts
-
A Method to Enhance Re-Endothelialization of Tissue Engineered Decellularized Allograft Heart Scaffolds
DownloadFall 2009
Allograft tissue is used to reconstruct cardiac birth defects but induces an immune response resulting in allo-sensitization. Decellularization reduces the immune response, however, acellular vascular tissue is thrombogenic. In-vitro endothelialization may attenuate thrombogenicity. Here we offer...
-
A Novel Nude Mouse Model of Hypertrophic Scarring Using Scratched Full-Thickness Human Skin Grafts
DownloadFall 2015
Hypertrophic scar (HTS) is a dermal form of fibroproliferative disorder that develops following deep skin injury. This dermal fibrosis can cause deformities, functional disabilities, and aesthetic disfigurements. The pathophysiology of HTS is not understood due in part, to the lack of an ideal...
-
Acetyl-L-carnitine to enhance nerve regeneration in carpal tunnel syndrome; a randomized controlled trial
DownloadFall 2017
Background Carpal tunnel syndrome (CTS) is the most common form of peripheral nerve injury, involving approximately 3% of the population. While surgery is effective in mild and moderate cases, neurologic and functional recovery are often not complete in severe cases. Therefore, there is a need...
-
Activation of Natural Killer T cells and Dendritic cells with Caulobacter crescentus: Implications for developing tumour immunity
DownloadSpring 2013
Cancer remains a leading cause of mortality worldwide. Efforts to develop immuno-therapies to control the growth of cancer, while limiting host cell damage, have focused on targeting specific tumour associated antigens. These treatments have yielded some clinical success however; the limited...